rashin karancin cutar sankara

Wanda ba karamin ilimin sel ciwon ciki ba (NSCLC) Zaɓuɓɓuka sun bambanta kuma sun dogara da mataki, subtypepe, da dalilai masu haƙuri. Magungunan gama gari sun hada da tiyata, kwanciyar hankali. Wannan jagorar tana bincika kowane zaɓi daki-daki, yana taimaka muku fahimtar yiwuwar yanke shawara da yanke shawara a cikin shawara tare da ƙungiyar likitancinku (NSCLC) Mene ne NSCLC?Rashin karancin cutar sel (NSCLC) shine mafi yawan nau'ikan cutar sankarar mahaifa, lissafin kusan 80-85% na duk shari'an cutar sankara na huhu. Kalmar laima ce wacce ta hada da wasu substepes, mafi yawan al'adar sel carcinoma laima, da kuma babban sel carcinoma laima, da kuma babban sel carcinoma laima, da babban sel carcinoma laima, da kuma babban claromaoma. An tabbatar da matakin ta hanyar girman da kuma inda ya dace da nodems na kusa, kuma yana da zaɓuɓɓukan zaɓuɓɓuka na NSClsurggensurery shine ainihin jiyya ga farkon-stage. Manufar shine don cire kumburi da kowane nodanni na kusa da na kusa wanda zai iya ƙunsar sel na cutar kansa. Lobectomy: Cire duka lobe na huhu. PNumonectomy: Cire duka huhu. Saka Cire karamin, weded-mai siffa na huhu. Sogementectomy: Cire wani yanki na huhu, wanda ya fi girma fiye da rani weji amma karami fiye da lebe.SAURARA: Mayu na iya zama zaɓi ga marasa lafiya tare da NSCLC ko waɗanda ke da yanayin kiwon lafiya waɗanda ke yin tiyata sosai. Ana iya amfani da shi don kula da NSCLC ta hanyoyi da yawa: Daski na waje na waje (obrt): An kawo radiation daga injin da ke bayan jiki. Storeotactic Jikin Radiapy (SBRT): Kyakkyawan ainihin hanyar Ebrrt wanda ke ba da babban kashi na radiation ga karamin yanki. Sau da yawa ana amfani da cutar sankara na farkon lokacin da tiyata ba mai yiwuwa bane. Brachythyiyya: Ana sanya kayan rediyo kai tsaye kai tsaye cikin ko kusa da ƙari. Mu a Shandong Cible Bincike Cibiyar Bincike fahimci mahimmancin hada jiyya don kyakkyawan sakamako. Baroa jagora ne a cikin hadewar cutar kansa kecewa yana amfani da magunguna don kashe sel na cutar kansa a jiki. Ana amfani da shi sau da yawa don magance ci gaba na NSCLC ko don hana cutar kansa daga maimaitawa bayan tiyata. Magunguna na gama gari na NSCLC sun hada da: Cisplatin Carboplatin Ducetaxel Paclitaxelcheothera, tare da lokutan magani sun biyo bayan lokacin hutawa. Tasirin sakamako na iya bambanta dangane da magunguna da mai haƙuri. Wadannan kwayoyi galibi suna da tasiri kuma suna da ƙarancin sakamako fiye da maganin ƙwaƙwalwa. The Arjited Arapies yawanci suna da marasa lafiya tare da takamaiman maye gurbi. Jigogi na yau da kullun sun haɗa da: Egfr: Cikakken sakamako mai ƙarfi AlK: Anagrus Rympoma Kinase ROS1: ROS1 Proto-Oncogene Receptor Tyrosine Kinase Braf: B-RAF Presto-Oncogene, Merine / Miyagun Kinase Ntrk: Idroxhic Tyssrophic Tyrosine Receporles Kinasexames kwayoyi da aka yi amfani da shi ga NSCTRTINIB (Tagotrif) Osinertinib (Alalceva) Erlotinib (Alalceva) Erlotinib (Alalceva) Erlotinib (Alalceva) Erlotinib (Alalceva) Erlotinib (Alalceva) Erlotinib (zykadia) erlotinib (zykadia) kafin farawa Farfesa, marasa lafiya yawanci suna iya yin gwajin kwayoyin halitta don sanin ko suna da maye gurbi.im nasiha don amfani da cutar kansa na jiki. Wadannan kwayoyi na iya toshe sunadarai waɗanda ke hana tsarin rigakafi daga ƙwayoyin cutar kansa. Magunguna na gama gari na NSCLC sun haɗa da: Keytrakam) Nivolumab (Opdivo) ana iya amfani da Durothumab (OpDIVO). Tasirin sakamako na iya haɗawa da gajiya, rashes fata, da kumburi da yawa gabobi.nclc jiyya ta hanyar matakai na farko ba na farko don mataki na nsclc. SBRT Za a iya ɗauka idan mai haƙuri ba ɗan takarar ne ba. MEALAGE II NSCLCTRTREMATSREMTICTICTERSTICTERS yawanci ya ƙunshi tiyata ya biyo bayan tiyata ya biyo bayan tiyata ya biyo baya. Hakanan za a yi amfani da fararen fata.stage III NII NSSCCTrefement don mataki na III NSCLC ya fi rikitarwa kuma yana iya haɗawa da tiyata, Chemotherapy, da maganin radiation. Hakanan za'a iya amfani da rigakanci bayan Cheroradiation a wasu halaye.stage IV NSCLCTTRTRETSISET OREVE IV NSCLC ya mai da shi kan sarrafa cutar kansa da kuma samar da alamu. Zaɓin na iya haɗawa da maganin chemothera, magani da aka yi niyya, ƙwaƙwalwar ajiya, da maganin radiation. Zabi na jiyya ya dogara ne da takamaiman halayen cutar kansa da kuma gwajin rashin kulawa gabaɗaya sune nazarin sabon magani don cutar kansa. Marasa lafiya tare da NSCLC na iya cancanci shiga cikin gwajin asibiti. Yi magana da likitanka don ƙarin koyo game da gwaji na asibiti kuma ko daidai ne a gare ku. Shandong Baofa Ceter Center Cibiyar Dokar bincike ta hanyar bincike yana nufin mu zauna a gefen yankan sabbin zaɓuɓɓukan bincike, wani lokacin ta hanyar yanke shawara mai kyau don tattaunawa da kungiyar kiwon lafiya. Abubuwan da za a yi la'akari da su sun haɗa da matakin da kuma subtype na cutar kansa, da lafiyar mai haƙuri, da abubuwan da suke so. Kada ku yi shakka a yi tambayoyi ku nemi ra'ayi na biyu idan da ake buƙata da ƙididdigar yawansu don NSCLC ya bambanta dangane da matakin cutar kansa, jiyya ta karɓa, da sauran dalilai. Gwajin farko da magani na iya inganta damar rayuwa. Mataki na 5-shekara tsira na shekaru 18-92% mataki na II 53-60% na III 13-30% na IV Kasa da 10% * Tushen:www.cancer.org) Rayuwa tare da NSClcliving tare da NSCLC na iya zama kalubale, amma akwai albarkatu masu yawa don taimakawa marasa lafiya da danginsu su jimre. Wadannan albarkatun sun hada da kungiyoyin tallafi, aiyukan shawarwarin, da shirye-shiryen taimakon kudi.